The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies
Clinical trial NCT06099925 · UNKNOWN
Trial details
- NCT number
- NCT06099925
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2025-09-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.